1. Home
  2. TARA vs XLAB Comparison

TARA vs XLAB Comparison

Compare TARA & XLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

SELL

Current Price

$2.30

Market Cap

159.6M

Sector

Health Care

ML Signal

SELL

Logo Exascale Labs Holdings Inc. Class A Common Stock

XLAB

Exascale Labs Holdings Inc. Class A Common Stock

N/A

Current Price

$1.81

Market Cap

146.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TARA
XLAB
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.6M
146.0M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
TARA
XLAB
Price
$2.30
$1.81
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
★ $25.33
N/A
AVG Volume (30 Days)
852.9K
★ 9.2M
Earning Date
11-06-2026
12-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.25
N/A
EPS
N/A
★ N/A
Revenue
$2,948,000.00
★ $14,822,799.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 111.29
52 Week Low
$2.09
$0.78
52 Week High
$7.82
$5.27

Technical Indicators

Market Signals
Indicator
TARA
XLAB
Relative Strength Index (RSI) 42.02 46.44
Support Level $2.19 $0.90
Resistance Level $2.73 $3.07
Average True Range (ATR) 0.21 0.50
MACD 0.03 -0.01
Stochastic Oscillator 34.43 34.30

Price Performance

Historical Comparison
TARA
XLAB

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

About XLAB Exascale Labs Holdings Inc. Class A Common Stock

Exascale Labs Holdings Inc is an AI infrastructure provider operating a software-defined GPU compute platform and related AI infrastructure solutions. Its core business includes GPU-as-a-Service (GaaS), through which it provides reserved and on-demand access to GPU compute capacity sourced from third-party data centers, as well as GPU cluster management and optimization services for AI data center (AIDC) operators. The business consists of two primary product and service categories: First, providing GPU-based compute services through its GaaS offering; Second, providing infrastructure solutions for AI deployments.

Share on Social Networks: